Health Care Deal News, January 6, 2014 - Medical Device Maker Stryker Corporation Started off 2014 Much the way it Ended 2013, Pharmaceutical Transactions Dominated the Largest Deals List for the Month of December

 

Brought to you by www.DealSearchOnline.com
 

January 6, 2014 Issue:

 

Recent Health Care M&A Deals

Medical Devices

 

 

Acquirer

Target

Price

AtriCure, Inc.

Estech

$34 million

Stryker Corporation

Patient Safety Technologies, Inc.

$120 million

Pharmaceuticals

 

 

Jazz Pharmaceuticals plc

Gentum S.p.A.

$1 billion

Shenzhen Hepalink Pharmaceutical Co., Ltd.

Scientific Protein Laboratories, LLC

$337.5 million

Physician Medical Groups

 

 

IPC The Hospitalist Company, Inc.

3 groups in MI and FL

N/A

 

Technology Deal of the Week
Medical device maker Stryker Corporation (NYSE: SYK) started off 2014 much the way it ended 2013: with another acquisition. On January 2, 2014, SYK announced a definitive agreement to acquire Patient Safety Technologies, Inc. (NASDAQ: PSTX) for $120 million, gaining its proprietary Safety-Sponge® System and SurgiCount 360™ compliance software. This deal comes on the heels of its $1.65 billion acquisition of MAKO Surgical Corp. (NASDAQ: MAKO), which closed on December 17. You may recall that last January, SYK paid $98.5 million for the Chinese orthopedics company, Trauson Holdings (HKSE: 325) and an undisclosed amount for certain non-core spinal implant technologies from Vertiflex Inc. in March. Here’s to a busy 2014 ......Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

Charted Territory
Pharmaceutical transactions dominated the Largest Deals List for the month of December, taking seven of the top 10 spots. The three outliers were Valeant Pharmaceuticals’ (NYSE: VRX) acquisition of medical device maker Solta Medical (NASDAQ: SLTM); Emergent BioSolutions’ (NYSE: EBS) deal for Canadian biotech company Cangene Corporation (TSX: CNJ.TO); and Centene Corporation’s (NYSE CNC) purchase of the privately held home health care company, U.S. Medical Management, LLC.


10 Largest Deals in December 2013

Acquirer

Target

Price

The Bayer Group

Algeta ASA

$2.9 billion

AstraZeneca plc

BMY’s global diabetes assets

$2.7 billion

Jazz Pharmaceuticals

Gentium

$1.0 billion

Covidien plc

Given Imaging Ltd.

$860 million

Shenzhen Hepalink Pharmaceuticals

Scientific Protein Laboratories

$337.5 million

Almirall, S.A.

Aqua Pharmaceutical Holdings

$327.6 million

Torrent Pharmaceuticals

Domestic formulations business

$320 million

Valeant Pharmaceuticals

Solta Medical

$250 million

Forest Laboratories

US rights to Saphris

$240 million

Emergent BioSolutions

Cangene Corporation

$222 million

Centene Corporation

U.S. Medical Management

$200 million

Source: The Health Care M&A News, December 2013

Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today

 

Services Deal of the Week
Aviv REIT, Inc. (NYSE: AVIV) closed two deals for four post-acute and skilled nursing facilities on December 23, for a total of $20 million. One of the SNFs is located in Texas and is triple-net leased to existing Aviv operator Fundamental Long Term Care, which operates 102 facilities in 13 states. The other three SNFs are located in Illinois and are triple-net leased to Bridgemark Healthcare, also an existing Aviv operator. The investments have a blended cash yield of 9.9%, annual escalators and initial lease terms of seven and 10 years, respectively.....Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

In the Pipeline
The Biotechnology sector made up more than half of all IPO activity in 2013, which is more than all the IPO activity in the previous five years combined, according to the National Venture Capital Association (NVCA) and the Exit Poll by Thomson Reuters. A total of 377 VC-backed deals were announced in 2013, of which 82 were IPOs, the NVCA said. Of the 90 that came with disclosed values, the total deal value was $14.5 billion, with an average deal size of $161.4 million. And they’re hoping for more activity in 2014, of course...... Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

Healthcare M&A Markets, Trends, Opportunities, Covered at iiBIG’s Annual Forum

Join senior-level healthcare finance executives, entrepreneurs, and investors for iiBIG’s 6th Annual Investment and M&A Opportunities in Healthcare conference, scheduled for January 27-28, 2014 at the Music City Center in Nashville, Tennessee. This year conference will cover latest in state of the healthcare M&A markets today and beyond 2014; private investing; roll-ups and mergers in the clinical research sector; middle market financing trends; the role of technology in healthcare M&A; investment opportunities and challenges in medicinal marijuana; distressed M&A opportunities; payer/provider convergence – implications of the trend toward IDNs (Integrated Delivery Networks); valuations, regulatory compliance, due diligence and more; and the “Healthcare Entrepreneur Roundtable” – growing through acquisitions and strategic partnerships. For more information, visit http://www.iibig.com/HealthcareMA or contact info@iibig.com.

 

2nd Annual Financing Innovation and Technology in Healthcare Conference - Friday, March, 14, 2014

This conference serves as a 1-day “think tank” which convenes leading financiers, entrepreneurs, academicians, policy makers and executives in healthcare to share insights into the dynamics of financing innovation and technology in the post-reform area.

The conference experience is enriched through relevant topics, influential speakers and networking opportunities. Healthcare industry leaders will discuss the following topics through a series of engaging panel sessions:

* How investments in healthcare innovation and technology can strengthen the economies of metropolitan areas

* Opportunities and challenges facing the medical device industry

* “Big Data” in healthcare

* Accelerating innovation through continued public and private sector R&D investment

Hosted by Amicus Capital Partners, LLC and the University of Chicago Booth School of Business Alumni Association

The Union League Club of Chicago
65 West Jackson Boulevard

Chicago, IL

For more information and to register visit

http://www.amicuscp.com/financing-healthcare-technology-conference.html

 

Around the Web in Health Care M&A...Click here to see more

 
Webcast Calendar...Click here to see more

 

Upcoming Conference Partnerships... Click here to see more